ea0020p358 | Diabetes and Cardiovascular | ECE2009
Unnikrishnan AG
, Shah Siddharth
, Asirvatham Arthur
, Chakkarwar Praful
, Moharana Ashok
, Kapoor Dheeraj
Aims & objectives: IMPROVE is a 6-month, multi-national, prospective, observational study, assessing the safety and efficacy of biphasic insulin aspart 30/70 (BiAsp 30) in patients with type 2 diabetes.Methods: We present the efficacy data from the Indian cohort of IMPROVE study. A total of 17 995 subjects entered the study and 16 942 subjects completed the study. BiAsp 30 was initiated and dose was adjusted at the physicians discretion, ...